These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12402932)

  • 21. [Thiazolidinediones: effect of the pioglitazone on hyperglycemia, dyslipidemia and cardiovascular risk].
    Tan MH
    Rev Clin Esp; 2003 Jan; 203(1):33-40. PubMed ID: 12605799
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardiovascular risk and cardiometabolic protection: role of glitazones.
    Petrazzi L; Grassi D; Polidoro L; D'Aurelio A; Croce G; Properzi G; Tiberti S; Desideri G; Ferri C
    J Nephrol; 2008; 21(6):826-35. PubMed ID: 19034866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and clinical efficacy of pioglitazone.
    Hanefeld M
    Int J Clin Pract Suppl; 2001 Sep; (121):19-25. PubMed ID: 11594240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticipated US approval for rosiglitazone and pioglitazone.
    Diabetes Obes Metab; 1999 May; 1(3):181-2. PubMed ID: 11220298
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thiazolidinediones in type 2 diabetes].
    Baum U
    Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pioglitazone in evaluation by IQWiG (Institute for Quality and Cost Effectiveness in Public Health)--tunnel vision instead of broad view].
    MMW Fortschr Med; 2008 Aug; 150(32-35):56-7. PubMed ID: 19009700
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
    Wilcox R; Kupfer S; Erdmann E;
    Am Heart J; 2008 Apr; 155(4):712-7. PubMed ID: 18371481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A miracle of salamization: positive divided by two equals negative.
    Iwamoto Y
    Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
    [No Abstract]   [Full Text] [Related]  

  • 30. [Glitazones--a new class of drugs in treatment of type 2 diabetes].
    Kleinwechter H
    Dtsch Med Wochenschr; 2002 Feb; 127(8):400-1. PubMed ID: 11859452
    [No Abstract]   [Full Text] [Related]  

  • 31. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
    MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
    [No Abstract]   [Full Text] [Related]  

  • 32. [World news in age-related diabetes: blood sugar lowering can improve prognosis].
    Einecke D
    MMW Fortschr Med; 2005 Sep; 147(38):1. PubMed ID: 16218218
    [No Abstract]   [Full Text] [Related]  

  • 33. Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
    Kane JP
    Diabetes Technol Ther; 2002; 4(2):153-5. PubMed ID: 12079618
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glitazones critically evaluated].
    Schernthaner G
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA approves pioglitazone for diabetes.
    Miller JL
    Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
    [No Abstract]   [Full Text] [Related]  

  • 36. [Infarct prevention for diabetics. To lower blood sugar is not enough].
    MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.
    Chilcott J; Wight J; Lloyd Jones M; Tappenden P
    Health Technol Assess; 2001; 5(19):1-61. PubMed ID: 11701097
    [No Abstract]   [Full Text] [Related]  

  • 38. Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials.
    Charbonnel B
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():19-20. PubMed ID: 18001315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 40. Pioglitazone-associated fulminant hepatic failure.
    Chase MP; Yarze JC
    Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.